XchangeWorx Revenue and Competitors
Estimated Revenue & Valuation
- XchangeWorx's estimated annual revenue is currently $3.7M per year.
- XchangeWorx's estimated revenue per employee is $141,400
Employee Data
- XchangeWorx has 26 Employees.
- XchangeWorx grew their employee count by 18% last year.
XchangeWorx's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Process and Release Management | Reveal Email/Phone |
2 | Director Operations and Software Quality | Reveal Email/Phone |
3 | Junior Software Engineer | Reveal Email/Phone |
XchangeWorx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.2M | 10 | 0% | N/A | N/A |
#2 | $0.9M | 9 | 0% | N/A | N/A |
#3 | $4.1M | 29 | 4% | N/A | N/A |
#4 | $35.1M | 158 | 5% | N/A | N/A |
#5 | $0.7M | 7 | 0% | N/A | N/A |
#6 | $19.6M | 97 | -5% | N/A | N/A |
#7 | $0.1M | 1 | -97% | N/A | N/A |
#8 | $3.8M | 27 | 4% | N/A | N/A |
#9 | $16.6M | 82 | -22% | $35M | N/A |
#10 | $1.5M | 12 | 9% | N/A | N/A |
What Is XchangeWorx?
XchangeWorx enables organizations within the healthcare community to quickly and cost-effectively deploy a comprehensive, connected healthcare solution. Our technology and population health management solutions are enabling delivery of the right information at the right time; driving efficient, effective and affordable healthcare, and creating meaningful value for each patient, clinician and organization we serve. We are continuing to expand and have several openings for talented, dedicated professionals to become a part of our team helping to shape the future of healthcare information technology.
keywords:N/AN/A
Total Funding
26
Number of Employees
$3.7M
Revenue (est)
18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.4M | 26 | -21% | N/A |
#2 | $1.8M | 26 | -4% | N/A |
#3 | $6M | 26 | 8% | N/A |
#4 | $4.9M | 26 | -4% | N/A |
#5 | N/A | 26 | 4% | N/A |